Intellia Therapeutics Inc

Cerrado

SectorSanidad

16.64 4.26

Resumen

Variación precio

24h

Actual

Mínimo

16.09

Máximo

16.71

Métricas clave

By Trading Economics

Ingresos

106M

-96M

Ventas

-8M

15M

BPA

-0.81

Margen de beneficios

-639.494

Empleados

377

EBITDA

1.4M

-94M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+26.26% upside

Dividendos

By Acuity

Próximas Ganancias

6 ago 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

573M

2.2B

Apertura anterior

12.38

Cierre anterior

16.64

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

110 / 342 Clasificación en Healthcare

Intellia Therapeutics Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

27 jun 2026, 00:02 UTC

ETF Constituents
News

SPDR Dow Jones Industrial Average ETF Trust rises in after-market trading amid geopolitical tensions and mixed U.S. equity performance, supported by gains from major companies.

27 jun 2026, 00:02 UTC

Social Media
News

Fox Corp shares are lower in after-hours trading, amid discussions on FIFA World Cup viewership and a proposed merger raising regulatory concerns.

27 jun 2026, 00:02 UTC

News

Fox Corp shares are lower in after-market hours, reflecting a decline from Friday's close despite increased soccer viewership during the FIFA World Cup.

26 jun 2026, 23:51 UTC

News

iShares 20+ Year Treasury Bond ETF declines in after-market trading amid heightened geopolitical tensions from military actions in the Middle East.

26 jun 2026, 23:41 UTC

News

Charter Communications is in talks with SpaceX for a partnership to enhance mobile services using Starlink, with shares trading higher in after-market hours.

26 jun 2026, 23:31 UTC

Social Media
News

Barclays raised its price target for Micron Technology, citing strong earnings and AI demand. Shares are higher in after-market trading alongside broader market gains.

26 jun 2026, 23:26 UTC

Social Media
News
ETF Constituents

Invesco QQQ Trust gains in after-market trading as retail sentiment turns bullish, contrasting with declines in the broader market amid tech sell-off.

26 jun 2026, 23:16 UTC

Social Media
News

Amazon's stock rises after AWS announces a notable price increase in Nvidia compute services. Wells Fargo maintains a Buy rating and sets a target of $312.

26 jun 2026, 23:06 UTC

News

Amgen Inc shares declined in after-market trading following its revenue projections of $37.1 billion to $38.5 billion and significant debt of $57 billion.

26 jun 2026, 23:02 UTC

News
ETF Constituents

SPDR Dow Jones Industrial Average ETF Trust rises in after-market trading, supported by gains from top holdings and the Dow's third consecutive weekly increase.

26 jun 2026, 23:02 UTC

Social Media
ETF Constituents
News

SPDR S&P 500 ETF Trust rises in after-market trading following S&P's affirmation of U.S. sovereign ratings, reflecting positive economic growth expectations.

26 jun 2026, 23:02 UTC

Social Media
News

The United States Oil Fund LP rose after military strikes in the Strait of Hormuz heightened concerns over oil supply stability and increased trading activity.

26 jun 2026, 23:02 UTC

Social Media
News

Fox Corp shares are trading lower in after-market hours, despite strong preliminary viewership for the USA vs. Turkiye World Cup match and merger discussions.

26 jun 2026, 23:01 UTC

News

Fox Corp shares are lower in after-market trading amid broader market concerns over inflation and weakening momentum in AI-driven stocks, despite strong viewership for FIFA matches.

26 jun 2026, 20:15 UTC

News
Correlated Moves
ETF Constituents

Vanguard Large-Cap ETF trades lower in after-market hours, reflecting declines in major holdings and a drop in the S&P 500 Index.

26 jun 2026, 20:07 UTC

Correlated Moves
News
Macro Event

Bitcoin is higher today, reflecting a slight gain since Thursday's close. The Goods Trade Balance widened to a record deficit of $105.8 billion.

26 jun 2026, 20:07 UTC

Macro Event
News
Correlated Moves

Bitcoin is higher during Friday's session, reflecting a slight gain since Thursday. Broader market sentiment appears to influence both Bitcoin and Ethereum.

26 jun 2026, 20:06 UTC

Correlated Moves
News

The US dollar's decline pressures USD/SGD, which has traded lower since Thursday. Broader inflation concerns are influencing the asset's performance today.

26 jun 2026, 20:06 UTC

News

The USD/NOK is higher today, supported by recent currency market dynamics. The US dollar declines amid falling oil prices and weak technology shares.

26 jun 2026, 20:05 UTC

Social Media
News

Tesla Inc. shares are higher, supported by a report showing 15.78% revenue growth and strong EBITDA of $2.43 billion, exceeding industry averages.

26 jun 2026, 20:05 UTC

Social Media
News
Correlated Moves

Shares of Alphabet Inc. are trading lower amid concerns about Waymo's impact on competitors, as noted in a recent BTIG analysis.

26 jun 2026, 20:05 UTC

Social Media
News

Microsoft shares are higher amid a market rally, fueled by Michael Burry's bullish sentiment and a valuation surpassing $2.75 trillion.

26 jun 2026, 20:04 UTC

News

Bank of America Securities reiterated its Buy rating on Ulta Beauty, setting a price target of $685 after a meeting with company executives. Shares are higher today.

26 jun 2026, 20:03 UTC

News
Correlated Moves
Social Media

Intel Corp shares are declining as the semiconductor sector faces pressure. High trading volume reflects increased investor activity amid mixed social media sentiment.

26 jun 2026, 20:02 UTC

News
Correlated Moves
Social Media

Applied Materials Inc shares are lower amid a decline in the Semiconductor Materials & Equipment sector, despite recent price target increases from analysts.

26 jun 2026, 19:56 UTC

News
Correlated Moves

The U.S. goods trade deficit widened to $105.8 billion in May 2026, influencing economic perceptions. Vanguard Total Bond Market ETF is higher since Thursday's close.

26 jun 2026, 19:56 UTC

News
Correlated Moves

The U.S. goods trade deficit widened to $105.8 billion in May 2026, potentially impacting economic perceptions and Federal Reserve interest rate decisions.

26 jun 2026, 19:52 UTC

Correlated Moves
News
Social Media

Broadcom Inc shares fell to $370.12, a 10-week low, amid a broader downturn in the semiconductor sector and negative investor sentiment.

26 jun 2026, 19:52 UTC

Social Media
News

Qualcomm Inc's stock is lower amid concerns over competition and supply shortages following its new chip architecture announcements for smartphones and data centers.

26 jun 2026, 19:52 UTC

Social Media
News
Correlated Moves

NVIDIA Corp shares are declining as Amazon Web Services raises GPU prices, potentially reducing demand. Market focus shifts to memory stocks amid broader pressures.

Comparación entre iguales

Cambio de precio

Intellia Therapeutics Inc previsión

Precio Objetivo

By TipRanks

26.26% repunte

Estimación a 12 Meses

Media 21.06 USD  26.26%

Máximo 49 USD

Mínimo 8 USD

De acuerdo con 18 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Intellia Therapeutics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

18 ratings

8

Comprar

8

Mantener

2

Vender

Sentimiento

By Acuity

110 / 342 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Intellia Therapeutics Inc

Intellia Therapeutics, Inc., a genome editing company, focuses on the development of curative therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; NTLA-2002 for the treatment of hereditary angioedema; and NTLA-3001 for alpha-1 antitrypsin deficiency associated lung disease. It also focusses on programs comprising hemophilia A and hemophilia B; and research of proprietary programs focused on developing engineered cell therapies to treat various cancers and autoimmune diseases. In addition, the company offers tools comprising of Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. It has license and collaboration agreement with Regeneron Pharmaceuticals, Inc. to co-develop potential products for the treatment of hemophilia A and hemophilia B; AvenCell Therapeutics, Inc. to develop allogeneic universal CAR-T cell therapies, and co-develop and co-commercialize allogeneic universal CAR-T cell products for an immuno-oncology indication; SparingVision SAS to develop novel genomic medicines utilizing CRISPR/Cas9 technology for the treatment of ocular diseases; Kyverna Therapeutics, Inc. for the development of an allogeneic CD19 CAR-T cell therapy for the treatment of a variety of B cell-mediated autoimmune diseases; and ONK Therapeutics, Ltd. for the development of engineered NK cell therapies to cure patients with cancer. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
help-icon Live chat